These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 25632187)

  • 1. β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma.
    Huang GL; Shen DY; Cai CF; Zhang QY; Ren HY; Chen QX
    World J Gastroenterol; 2015 Jan; 21(4):1148-57. PubMed ID: 25632187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma.
    Shen DY; Zhang W; Zeng X; Liu CQ
    Cancer Sci; 2013 Oct; 104(10):1303-8. PubMed ID: 23822562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis of human cholangiocarcinoma cell lines induced by β-escin through mitochondrial caspase-dependent pathway.
    Shen DY; Kang JH; Song W; Zhang WQ; Li WG; Zhao Y; Chen QX
    Phytother Res; 2011 Oct; 25(10):1519-26. PubMed ID: 21394804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.
    Lim K; Han C; Xu L; Isse K; Demetris AJ; Wu T
    Cancer Res; 2008 Jan; 68(2):553-60. PubMed ID: 18199552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway.
    Cheng H; Li Q
    BMC Gastroenterol; 2023 Aug; 23(1):279. PubMed ID: 37568083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen reverses the multi-drug-resistance of an established human cholangiocarcinoma cell line in combined chemotherapeutics.
    Liu ZH; Ma YL; He YP; Zhang P; Zhou YK; Qin H
    Mol Biol Rep; 2011 Mar; 38(3):1769-75. PubMed ID: 20835928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.
    Zhang KS; Zhou Q; Wang YF; Liang LJ
    Oncol Rep; 2013 Sep; 30(3):1430-8. PubMed ID: 23799613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin Enhances the Drug Sensitivity of Cholangiocarcinoma through the Inhibition of Chemotherapeutic-Induced Autophagy.
    Hong ZF; Zhao WX; Yin ZY; Xie CR; Xu YP; Chi XQ; Zhang S; Wang XM
    PLoS One; 2015; 10(5):e0121538. PubMed ID: 25933112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.
    Buranrat B; Prawan A; Kukongviriyapan U; Kongpetch S; Kukongviriyapan V
    World J Gastroenterol; 2010 May; 16(19):2362-70. PubMed ID: 20480521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.
    Meng F; DeMorrow S; Venter J; Frampton G; Han Y; Francis H; Standeford H; Avila S; McDaniel K; McMillin M; Afroze S; Guerrier M; Quezada M; Ray D; Kennedy L; Hargrove L; Glaser S; Alpini G
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G759-68. PubMed ID: 24603459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma.
    Wang W; Zhong W; Yuan J; Yan C; Hu S; Tong Y; Mao Y; Hu T; Zhang B; Song G
    Oncotarget; 2015 Dec; 6(39):42276-89. PubMed ID: 26474277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wnt5a modulates vincristine resistance through PI3K/Akt/GSK3β signaling pathway in human ovarian carcinoma SKOV3/VCR cells].
    Wu FL; Chen HL; Hu XW; Liang LY; Xu WL
    Sheng Li Xue Bao; 2019 Jun; 71(3):415-423. PubMed ID: 31218332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
    Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
    Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma - cell line findings.
    Sriraksa R; Limpaiboon T
    Asian Pac J Cancer Prev; 2013; 14(4):2503-8. PubMed ID: 23725164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin signaling pathway and thioredoxin-interacting protein (TXNIP) mediate the "glucose sensor" mechanism in metastatic breast cancer-derived cells MDA-MB-231.
    Vaira S; Friday E; Scott K; Conrad S; Turturro F
    J Cell Physiol; 2012 Feb; 227(2):578-86. PubMed ID: 21448924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.
    Zhang GF; Qiu L; Yang SL; Wu JC; Liu TJ
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32140709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3β regulates the proliferation of glioma cells through the GSK3β/β-catenin signaling pathway.
    Gong F; Wang G; Ye J; Li T; Bai H; Wang W
    Oncol Rep; 2013 Dec; 30(6):2976-82. PubMed ID: 24065186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.